The key takeaway from Part I is that, across regions, personalisation is not a single global trend expressed uniformly around the world.
The underlying consumer desire for relevance and individualised experiences may be universal, but the way those needs are translated into products, formats, dosing strategies and purchasing behaviours varies considerably.
Successful personalisation strategies therefore must be modular, locally informed and adaptable to diverse consumer expectations.
Cultural norms, medication experience and daily use: Cultural context introduces an additional layer of nuance beyond regional differences.

Expectations about dosage forms, taste, texture and frequency are shaped by deeply rooted norms that influence both adoption and persistence.
In some cultures, flavoured or confectionery‑like formats are embraced for their convenience and enjoyment, particularly in daily-use products.
In others, these same attributes are viewed with scepticism; overly pleasant formats can be perceived as less “medicinal” and therefore less effective.
This highlights an important distinction: sensory optimisation is not universally valued.